Literature DB >> 21168490

A Quality by Design approach to investigate tablet dissolution shift upon accelerated stability by multivariate methods.

Jun Huang1, Chimanlall Goolcharran, Krishnendu Ghosh.   

Abstract

This paper presents the use of experimental design, optimization and multivariate techniques to investigate root-cause of tablet dissolution shift (slow-down) upon stability and develop control strategies for a drug product during formulation and process development. The effectiveness and usefulness of these methodologies were demonstrated through two application examples. In both applications, dissolution slow-down was observed during a 4-week accelerated stability test under 51°C/75%RH storage condition. In Application I, an experimental design was carried out to evaluate the interactions and effects of the design factors on critical quality attribute (CQA) of dissolution upon stability. The design space was studied by design of experiment (DOE) and multivariate analysis to ensure desired dissolution profile and minimal dissolution shift upon stability. Multivariate techniques, such as multi-way principal component analysis (MPCA) of the entire dissolution profiles upon stability, were performed to reveal batch relationships and to evaluate the impact of design factors on dissolution. In Application II, an experiment was conducted to study the impact of varying tablet breaking force on dissolution upon stability utilizing MPCA. It was demonstrated that the use of multivariate methods, defined as Quality by Design (QbD) principles and tools in ICH-Q8 guidance, provides an effective means to achieve a greater understanding of tablet dissolution upon stability.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168490     DOI: 10.1016/j.ejpb.2010.12.012

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  4 in total

1.  Development and Validation of a Discriminatory Dissolution Model for an Immediately Release Dosage Form by DOE and Statistical Approaches.

Authors:  Mingkun Fu; Ellen Conroy; Michael Byers; Lakshminarasimhan Pranatharthiharan; Thierry Bilbault
Journal:  AAPS PharmSciTech       Date:  2021-04-21       Impact factor: 3.246

2.  Formulation, Optimization, and Evaluation of Oregano Oil Nanoemulsions for the Treatment of Infections Due to Oral Microbiota.

Authors:  Khaled Hosny; Hani Asfour; Waleed Rizg; Nabil A Alhakamy; Amal Sindi; Hala Alkhalidi; Walaa Abualsunun; Rana Bakhaidar; Alshaimaa M Almehmady; Sara Akeel; Sarah Ali; Adel Alghaith; Sultan Alshehri; Rasha Khallaf
Journal:  Int J Nanomedicine       Date:  2021-08-13

3.  Coconut Oil Nanoemulsion Loaded with a Statin Hypolipidemic Drug for Management of Burns: Formulation and In Vivo Evaluation.

Authors:  Khaled M Hosny; Nabil A Alhakamy; Amal M Sindi; Rasha A Khallaf
Journal:  Pharmaceutics       Date:  2020-11-07       Impact factor: 6.321

4.  Development, optimization and characterization of nanoemulsion loaded with clove oil-naftifine antifungal for the management of tinea.

Authors:  Adel F Alghaith; Sultan Alshehri; Nabil A Alhakamy; Khaled M Hosny
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.